Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
![Alex Azar](https://www.radiohc.cu/articles/3471-alex-azar-secretary.jpeg)
Matérias relacionadas
Comentários
Deixe um comentário
Todos os campos são requeridosMais vistas
- Entram em vigor as normas para garantir as eleições presidenciais na Venezuela
- Díaz-Canel envia mensagem de incentivo aos atletas cubanos em Paris 2024
- Venezuela agradece felicitações cubanas pelo resultado das eleições
- Vitórias de Cuba no boxe e no vôlei de praia em Paris 2024
- A paz e o diálogo venceram na Venezuela